Pembrolizumab for Hepatocellular Carcinoma User Reviews
Brand names: Keytruda
- Jane
- Taken for less than 1 month
- September 18, 2020
Keytruda (pembrolizumab) "One treatment of Keytruda finished off my Husband within 3 months. The doctors tried steroids to stop keytruda effects, but nothing worked. Doctor did not even type his liver cancer before giving keytruda."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Hepatocellular Carcinoma
Care guides
Symptoms and treatments
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (227)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Keytruda (pembrolizumab) "I did five treatments with keytruda and my tumors were stable up until the 5th where they doubled in size so I immediately stop keytruda. Now I am currently taking lenvima 10 mg pill once per day we'll see how that works out not very hopeful though seems like I'm running out of options."